ESRX - Express Scripts Holding Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
96.90
-0.74 (-0.76%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close97.64
Open97.70
Bid96.70 x 1300
Ask97.06 x 800
Day's Range96.47 - 97.96
52 Week Range60.63 - 100.43
Volume1,919,071
Avg. Volume3,829,806
Market Cap54.613B
Beta (3Y Monthly)0.93
PE Ratio (TTM)11.22
EPS (TTM)8.64
Earnings DateOct 22, 2018 - Oct 26, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2003-11-12
1y Target Est92.93
Trade prices are not sourced from all markets
  • PR Newswireyesterday

    Petco and Express Scripts Team Up to Revolutionize Home Delivery of Pet Medicines

    SAN DIEGO and ST. LOUIS, Nov. 19, 2018 /PRNewswire/ -- Petco and Express Scripts (ESRX), a healthcare company focused on delivering personalized solutions to improve healthcare, today announced a new strategic alliance that will enable millions of pet parents to order and receive pet medicines from the comfort and convenience of home. Pet parents spend more than $8 billion annually on prescription and over-the-counter (OTC) medications for their animals. Petco now offers pet parents access to the pet prescriptions and OTC medications their pets need online via petco.com and petcoach.co for delivery directly to their front door, all Powered by Express Scripts.

  • Lower Drug Prices Get an Assist From a Big Player
    Bloomberg5 days ago

    Lower Drug Prices Get an Assist From a Big Player

    The list prices that pharmaceutical companies set for their drugs diverge wildly from their real cost, and PBMs widen and feast on the gap, which helps make them some of the principal beneficiaries of America’s byzantine pricing system. One of the main services PBMs provide are so-called drug formularies, or tiered lists of medicines, where drugs deemed “preferred” are much cheaper than those that are “excluded.” Preferred status on a major formulary can add millions in sales volume, and drugmakers offer huge rebates in order to secure it.

  • Walmart, Home Depot adopt health insurer tactic in drug copay battle
    Reuters7 days ago

    Walmart, Home Depot adopt health insurer tactic in drug copay battle

    Walmart (WMT.N) and Home Depot (HD.N), two of the top 10 U.S. employers, have embraced a health insurance strategy that punishes drugmakers for using discount cards to keep patients from switching or stopping their medications. Large U.S. companies have started tightly managing how employees and their family members use these popular discount, or copay, cards for everything from multiple sclerosis treatments to widely-used rheumatoid arthritis medications sold through a specialty pharmacy.

  • PR Newswire7 days ago

    Express Scripts Introduces Novel Formulary Built for Evolution of Drug Pricing

    - New National Preferred Flex Formulary provides employers and health plans a pathway to cover lower list price products, help deliver lower member out-of-pocket costs, and reduce reliance on brand rebates. - Authorized alternatives for hepatitis C therapies Epclusa® and Harvoni® among first products to be available through Express Scripts' National Preferred Flex Formulary. ST. LOUIS, Nov. 13, 2018 /PRNewswire/ -- As drug pricing strategies continue to evolve, Express Scripts (ESRX) is keeping clients ahead of the game.

  • Reuters7 days ago

    Express Scripts offers new formulary for lower list-price drugs

    Express Scripts Holding Co on Tuesday announced a new drug reimbursement list with lower U.S. prices for brand-name medications, as a way to encourage drugmakers to move away from paying rebates after a prescription is filled. The manager of prescription drug benefits for large corporate employers and government health plans said its new National Preferred Flex Formulary will be available as of Jan. 1 to all clients. Drug rebates have come under fire from the Trump Administration and consumer groups as patients find themselves paying much higher insurance co-payments and deductibles tied to a drug's sticker price.

  • See what the IHS Markit Score report has to say about Express Scripts Holding Co.
    Markit11 days ago

    See what the IHS Markit Score report has to say about Express Scripts Holding Co.

    Express Scripts Holding Co NASDAQ/NGS:ESRX

  • GuruFocus.com12 days ago

    Jeff Auxier Comments on Express Scripts Holding

    Guru stock highlight

  • PR Newswire14 days ago

    Express Scripts' myMatrixx Launches myDataSense Analytics Tool

    ST. LOUIS and TAMPA, Fla. , Nov. 6, 2018 /PRNewswire/ -- myMatrixx®, a leader in pharmacy services for workers' compensation programs and a subsidiary of Express Scripts Holding Company (NASDAQ: ESRX), ...

  • See what the IHS Markit Score report has to say about Express Scripts Holding Co.
    Markit14 days ago

    See what the IHS Markit Score report has to say about Express Scripts Holding Co.

    Express Scripts Holding Co NASDAQ/NGS:ESRX

  • The Zacks Analyst Blog Highlights: Verizon, Express Scripts, Cigna, Ecolab and eBay
    Zacks15 days ago

    The Zacks Analyst Blog Highlights: Verizon, Express Scripts, Cigna, Ecolab and eBay

    The Zacks Analyst Blog Highlights: Verizon, Express Scripts, Cigna, Ecolab and eBay

  • 'Centene effect': What impact the managed health care provider, Cortex are having on St. Louis office scene
    American City Business Journals15 days ago

    'Centene effect': What impact the managed health care provider, Cortex are having on St. Louis office scene

    Almost 170,000 square feet of positive absorption took place during the third quarter, with the Cortex tech district leading the way with 90,000 square feet.

  • Top Stock Reports for Verizon, Express Scripts & Cigna
    Zacks18 days ago

    Top Stock Reports for Verizon, Express Scripts & Cigna

    Top Stock Reports for Verizon, Express Scripts & Cigna

  • ESRX or HQY: Which Is the Better Value Stock Right Now?
    Zacks18 days ago

    ESRX or HQY: Which Is the Better Value Stock Right Now?

    ESRX vs. HQY: Which Stock Is the Better Value Option?

  • Express Scripts (ESRX) Soars to 52-Week High, Time to Cash Out?
    Zacks18 days ago

    Express Scripts (ESRX) Soars to 52-Week High, Time to Cash Out?

    Express Scripts (ESRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

  • Cigna Corp (CI) Q3 2018 Earnings Conference Call Transcript
    Motley Fool19 days ago

    Cigna Corp (CI) Q3 2018 Earnings Conference Call Transcript

    CI earnings call for the period ending September 30, 2018.

  • Morningstar19 days ago

    Improving Results for Express Scripts

    The Cigna merger is on track, and we are maintaining our $92 fair value estimate and wide moat rating after a solid quarter for Express Scripts.

  • Stock Market News For Nov 1, 2018
    Zacks19 days ago

    Stock Market News For Nov 1, 2018

    Wall Street ended a disastrous October on Wednesday on a winning note buoyed by strong third quarter earnings results from major brand names

  • Reuters19 days ago

    Cigna says Express Scripts deal to close by end of year

    Cigna Corp said on Thursday its $52-billion acquisition of pharmacy benefits manager Express Scripts Holding Co was on track to close by the end of the year. Chief Executive Officer David Cordani said ...

  • Express Scripts (ESRX) Tops Q3 Earnings & Revenue Estimates
    Zacks19 days ago

    Express Scripts (ESRX) Tops Q3 Earnings & Revenue Estimates

    Express Scripts' (ESRX) Q3 results hurt by year-over-year decline in adjusted network claims, thanks to the loss of certain public sector clients.

  • Investing.com19 days ago

    Express Scripts Earnings, Revenue beat in Q3

    Investing.com - Express Scripts (NASDAQ:ESRX) reported third quarter earnings that beat analyst's expectations on Wednesday and revenue that topped forecasts.

  • Express Scripts (ESRX) Q3 Earnings and Revenues Surpass Estimates
    Zacks20 days ago

    Express Scripts (ESRX) Q3 Earnings and Revenues Surpass Estimates

    Express Scripts (ESRX) delivered earnings and revenue surprises of 0.41% and 2.28%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

  • InvestorPlace20 days ago

    ExpressScripts Stock Is Trading Flat Despite Earnings Beat

    ExpressScripts stock (NASDAQ:ESRX) did not experience much movement late in the day Wednesday as the company unveiled its latest quarterly earnings results, which were just a touch above what analysts were calling for in their consensus estimate. When adjusted for one-time gains and costs, ExpressScripts brought in earnings of $2.43 per share. The figure was slightly ahead of what the Wall Street consensus estimate projected as the average guidance of 11 analysts surveyed by Zacks Investment Research called for net income of $2.42 per share.

  • Associated Press20 days ago

    Express Scripts: 3Q Earnings Snapshot

    The St. Louis-based company said it had profit of $1.89 per share. Earnings, adjusted for one-time gains and costs, came to $2.43 per share. The results beat Wall Street expectations. The average estimate ...

  • Capital Exchange: Express Scripts CEO on the intersection...
    CNBC Videos5 days ago

    Capital Exchange: Express Scripts CEO on the intersection...

    Express Scripts CEO Tim Wentworth explains at our Capital Exchange: Longevity Economy event in DC that with close to 25% of his employees over 50, there’s varying degrees of skill adaptation. He’s seen an inclusive culture that that allows people to he...

  • Cigna CEO on earnings and pending Express Scripts merger
    CNBC Videos19 days ago

    Cigna CEO on earnings and pending Express Scripts merger

    Cigna President and CEO David Cordani joins 'Squawk on the Street' to discuss the company's quarterly earnings, the pending merger with Express Scripts, future growth and medical marijuana.